Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial – The Lancet   Commentary on Twitter The PRINCIPLE trial publishes its first peer reviewed paper, showing results from the study of azithromycin as a treatment for […]

The post RCT: Azithromycin provides no benefit for community treatment of patients with suspected COVID-19 appeared first on Links Medicus.